Erlotinib therapy for Olmsted syndrome with p.L655P missense mutation in the TRPV3 gene: a case report

Erlotinib therapy for Olmsted syndrome with p.L655P missense mutation in the TRPV3 gene: a case report

Olmsted syndrome (OS) is a rare disorder characterized by a mutilating palmoplantar keratoderma and periorificial keratotic plaques, but which shows considerable clinical heterogeneity. Recently, transient receptor potential vanilloid 3 (TRPV3) mutations associated with autosomal dominant or recessi...

Full description

Saved in:
Bibliographic Details
Main Authors: Jia Zhang, MengYue Guo, DongYang Yuan, JinYang Wei, Hongzhou Cui
Format: Article
Language:English
Published: Frontiers Media S.A. 2025-01-01
Series:Frontiers in Medicine
Subjects:
Olmsted syndrome
erlotinib
TRPV3 gene
missense mutation
case report
Online Access:https://www.frontiersin.org/articles/10.3389/fmed.2025.1512673/full
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items